Coronavirus (COVID-19)
Learn more
MSK 17-409, A Prospective Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent with Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma.
The purpose of this study is to demonstrate that participants with HPV positive and hypoxia negative T1-2, N1-2c (AJCC, 7th ed.) oropharyngeal squamous cell carcinoma receiving a major de-escalated radiation therapy with 2 cycles of standard chemotherapy is not inferior to comparable subjects treated with the current standard chemoradiation.
Eligibility Criteria
This study is for patients age 18 Years and older.
Available at: Hartford Hospital
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209